Why is Informative Censoring a Concern in Cancer Research?
In cancer research, patients may leave a study due to severe side effects from treatment, rapid disease progression, or even death. If these reasons are related to the study’s endpoint, such as survival rate or disease-free survival, the censoring is informative. This can lead to an overestimation or underestimation of the treatment effect, thereby compromising the study's validity.
